http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008505082-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 2005-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008505082-A |
| titleOfInvention | Method for presensitizing cancer prior to treatment with radiation and / or chemotherapy and novel cytokine mixtures |
| abstract | The present invention relates to an innovative method for presensitizing cancer prior to therapeutic treatment such as chemotherapy, radiation therapy or immunotherapy, and a novel cytokine mixture for use in the method. The cytokine mixture is a serum and mitogen-free mixture composed of specific ratios of cytokines such as IL-1β, TNF-α, IFN-γ and GM-CSF to interleukin-2 (IL-2), This is effective in inducing the entry of cancerous cells into the proliferative phase of the cell cycle, thereby increasing their sensitivity to chemotherapy, radiation therapy and immunotherapy. One such novel cytokine mixture is leukocyte interleukin injection (LI) or Multikine®, which can be used alone or in combination with other drugs for the treatment of cancer, thereby The success rate of cancer treatment and disease-free survival of cancer patients can be increased. [Selection figure] None |
| priorityDate | 2004-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 415.